Harbin Pharmaceutical Group Co Ltd (HPGC) is a pharmaceutical company that focuses on the research and development, manufacturing and commercialization of pharmaceutical products. It provides antibiotics, OTC and healthcare products, traditional and modern Chinese medicine, biomedicine, pharmaceutical and animal vaccines business. The company’s product portfolio includes calcium gluconate oral solution, zinc gluconate oral solution, pediatric paracetamol, lacidipine tablets, penicillin sodium for injection and amoxicillin capsules, among others. HPGC manufactures products in therapeutic areas such as anti-infection, cardiovascular and cerebrovascular, cold medicine, digestive system, anti-tumor drugs and nutritional supplements. HPGC is headquartered in Harbin, Heilongjiang, China.
Headquarters
China
Address
No. 7 Qunli Avenue, Daoli District, Haerbin, Heilongjiang, 150070
Website
www.hayao.com
Telephone
86 451 51870077
No of Employees
9,853
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
600664 (SHA)
Revenue (2022)
$2.2B
11.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-14.9%
(2022 vs 2021)
Market Cap*
$971.8M
Net Profit Margin (2022)
XYZ
-23.8%
(2022 vs 2021)
* As of and is in US$
Harbin Pharmaceutical Group Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Product: |
| Calcium Gluconate Oral Solution |
| Zinc Gluconate Oral Solution |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Harbin Pharmaceutical Group Co Ltd | Shenzhen Neptunus Bioengineering Co Ltd | Huadong Medicine Co Ltd | Shandong Buchang Pharmaceutical Co Ltd | KPC Pharmaceuticals Inc |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | China |
| City | Haerbin | Shenzhen | Hangzhou | Heze | Kunming |
| State/Province | Heilongjiang | Guangdong | Zhejiang | Shandong | Yunnan |
| No. of Employees | 9,853 | 9,874 | 14,061 | 8,491 | 5,051 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Zhang Yichen | Chairman | Executive Board | 2021 | 60 |
| Hu Xiaoping | Vice Chairman | Executive Board | 2022 | 53 |
| Liu Bo | Deputy General Manager; Chief Financial Officer | Senior Management | 2015 | 60 |
| Jiang Haitao | Deputy General Manager | Senior Management | 2022 | 41 |
| Meng Xiaodong | Deputy General Manager; Secretary | Senior Management | 2010 | 51 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward